About
Monteris NeuroBlate is a state-of-the-art medical device platform that represents the gold standard in minimally invasive laser ablation technology for the brain. Developed by Monteris Medical, the NeuroBlate System is the only robotic, MRI-guided laser interstitial thermal therapy (LITT) tool cleared for use in treating brain tumors, radiation necrosis, and drug-resistant epilepsy. By leveraging real-time MR thermometry and robotic precision, the system allows neurosurgeons to deliver targeted thermal energy to pathological tissue while minimizing damage to surrounding healthy brain structures. The platform is designed for use in hospital and surgical center environments, offering seamless integration with MRI suites. Monteris distinguishes itself through its commitment to generating prospective, multi-center clinical evidence — providing oncologists, neurosurgeons, and epileptologists with the data they need to justify treatment decisions and improve patient outcomes. The NeuroBlate System supports comprehensive clinical workflows from pre-operative planning through intraoperative guidance and post-operative follow-up. It is intended for use by trained healthcare professionals and comes with dedicated reimbursement support, instructions for use, and clinical research resources. Monteris serves patients and caregivers through a physician-finder tool and educational resources, making the technology more accessible across North America.
Key Features
- Robotic MR-Guided Precision: The NeuroBlate System is the only robotic MRI-guided laser ablation tool, enabling sub-millimeter targeting accuracy within the brain.
- Real-Time MR Thermometry: Intraoperative MR thermometry allows surgeons to monitor and control thermal energy delivery in real time, maximizing safety and efficacy.
- Multi-Indication Coverage: Cleared for brain tumors, radiation necrosis, and drug-resistant epilepsy, providing broad applicability across neurosurgical and epilepsy subspecialties.
- Prospective Clinical Evidence: Monteris is uniquely committed to multi-center prospective clinical research, giving physicians the evidence needed to support patient care decisions.
- Reimbursement & Clinical Support: Dedicated reimbursement guidance, IFU documentation, and clinical research resources support healthcare professionals throughout adoption and use.
Use Cases
- Minimally invasive laser ablation of primary and metastatic brain tumors in neurosurgical oncology settings.
- Treatment of radiation necrosis in patients who have previously undergone brain radiation therapy.
- Surgical management of drug-resistant epilepsy when traditional open resection is not viable or poses excessive risk.
- Real-time intraoperative MR-guided thermal monitoring during laser neurosurgical procedures.
- Clinical research and prospective evidence generation for LITT outcomes in neuro-oncology and epilepsy.
Pros
- Minimally Invasive Approach: LITT significantly reduces patient trauma compared to open neurosurgery, enabling faster recovery and shorter hospital stays.
- Strong Clinical Evidence Base: Backed by prospective, multi-center clinical data, giving neurosurgeons and oncologists confidence in treatment outcomes.
- Broad Clinical Indications: Addresses multiple complex neurological conditions — brain tumors, radiation necrosis, and drug-resistant epilepsy — with a single platform.
- Real-Time Intraoperative Feedback: MR-guided thermal monitoring provides live feedback during procedures, improving surgeon control and patient safety.
Cons
- Requires Specialized Infrastructure: The system requires an MRI suite and specialized neurosurgical training, limiting access to well-equipped tertiary care centers.
- High Cost of Adoption: As a capital medical device, the NeuroBlate System involves significant upfront investment and ongoing procedural costs.
- Not a Consumer or General-Purpose AI Tool: Strictly intended for trained neurosurgical professionals in clinical settings; not applicable to general research or non-medical AI use cases.
Frequently Asked Questions
What is the NeuroBlate System used for?
The NeuroBlate System is a robotic, MR-guided laser ablation platform used to treat brain tumors, radiation necrosis, and drug-resistant epilepsy using minimally invasive laser interstitial thermal therapy (LITT).
How does MR guidance improve the procedure?
MR guidance provides real-time thermometry and visualization during the ablation, allowing surgeons to precisely monitor heat delivery and protect surrounding healthy brain tissue.
Is the NeuroBlate System available in Canada?
Yes, Monteris operates both a U.S. office in Minnetonka, MN and a Canadian office in Winnipeg, MB, supporting clinical adoption across North America.
What clinical evidence supports the NeuroBlate System?
Monteris is committed to prospective multi-center clinical trials and evidence generation. Clinical research data is available for healthcare professionals through the Monteris website.
How can patients find a physician who uses NeuroBlate?
Monteris provides a 'Find a Physician' tool on their website, allowing patients and caregivers to locate trained neurosurgeons who perform NeuroBlate procedures.
